Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke

被引:0
|
作者
Cloutier, Justin M. [2 ,3 ]
Khoo, Clarence [2 ,3 ]
Hiebert, Brett [2 ]
Wassef, Anthony [4 ]
Seifer, Colette M. [1 ,2 ]
机构
[1] Univ Manitoba, Sect Cardiol, WRHA Cardiac Sci Program, Winnipeg, MB R2H 2A6, Canada
[2] St Boniface Gen Hosp, Cardiac Sci Program, Y3019, Winnipeg, MB R2H 2A6, Canada
[3] Univ Manitoba, Sect Cardiol, Winnipeg, MB, Canada
[4] Univ Toronto, Div Cardiol, Toronto, ON, Canada
关键词
anticoagulation; atrial fibrillation; devices; subclinical;
D O I
10.1177/1753944717749739
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objectives of this study were to evaluate the effectiveness of a physician notification system for atrial fibrillation (AF) detected on cardiac devices, and to assess predictors of anticoagulation in patients with device-detected AF. Methods: In 2013, a physician notification system for AF detected on a patient's CIED [including pacemakers, implantable cardioverter defibrillators (ICD) or cardiac resynchronization therapy (CRT) devices] was implemented, with a recommendation to consider oral anticoagulation in high-risk patients. We prospectively investigated the effectiveness of this system, and evaluated both patient and physician predictors of anticoagulation, as well as factors influencing physician decision making in prescribing anticoagulation. Both uni- and multivariable analysis as well as descriptive statistics were used in the analysis. Results: We identified 177 patients with device-detected AF, 126 with a CHADS(2) >= 2. Only 41% were prescribed anticoagulation at any point within 12 months. On multivariable analysis, stroke risk as predicted by CHADS(2) was not a predictor of anticoagulation. ASA use predicted a lower rate of anticoagulation (OR 0.39, 95% CI 0.16-0.97, p = 0.04); physicians in practice for <20 years were more likely to prescribe anticoagulation (OR 3.39, 95% CI 1.28-8.93, p = 0.01); and physicians who believed both cardiologist and family doctor should be involved in managing anticoagulation were more likely to prescribe anticoagulation (OR 3.28, 95% CI 1.02-10.5, p = 0.05). Conclusions: Patients on aspirin were less likely to be anticoagulated. Physicians in practice for <20 years and who believed that both the general practitioner and cardiologist should be involved in managing anticoagulants were more likely to prescribe anticoagulation.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 50 条
  • [1] PHYSICIAN DECISION MAKING IN ANTICOAGULATING ATRIAL FIBRILLATION: A PROSPECTIVE SURVEY EVALUATING A PHYSICIAN ALERT SYSTEM FOR ATRIAL FIBRILLATION DETECTED ON CARDIAC IMPLANTABLE ELECTRONIC DEVICES
    Cloutier, Justin
    Khoo, Clarence
    Hiebert, Brett
    Wassef, Anthony
    Seifer, Colette
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 837 - 837
  • [2] PHYSICIAN VARIATION IN ANTICOAGULATING PATIENTS WITH ATRIAL-FIBRILLATION
    CHANG, HJ
    BELL, JR
    DEROO, DB
    KIRK, JW
    WASSON, JH
    ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (01) : 83 - 86
  • [3] PHYSICIAN VARIATION IN ANTICOAGULATING PATIENTS WITH ATRIAL-FIBRILLATION
    HORBER, F
    STEIGER, U
    THERAPEUTISCHE UMSCHAU, 1992, 49 (05) : 365 - 366
  • [4] Impact of stroke events in Japanese patients with atrial fibrillation detected by cardiac implantable electronic devices
    Nakano, M.
    Kondo, Y.
    Nakano, M.
    Miyazawa, K.
    Hayashi, T.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1276 - 1277
  • [5] Impact of Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices on Embolic Stroke Events in Cancer Patients
    Nakano, Miyo
    Kondo, Yusuke
    Nakano, Masahiro
    Kajiyama, Takatsugu
    Ito, Ryo
    Chiba, Toshinori
    Sugawara, Masafumi
    Yoshino, Yutaka
    Ryuzaki, Satoko
    Komai, Yuya
    Takanashi, Yukiko
    Kobayashi, Yoshio
    CIRCULATION, 2023, 148
  • [6] Clinical significance of atrial fibrillation detected by cardiac implantable electronic devices
    DeCicco, Anthony E.
    Finkel, Jonathan B.
    Greenspon, Arnold J.
    Frisch, Daniel R.
    HEART RHYTHM, 2014, 11 (04) : 719 - 724
  • [7] Risk of Atrial Fibrillation and Adverse Outcomes in Patients With Cardiac Implantable Electronic Devices
    Lee, So-Ryoung
    Lee, Ji Hyun
    Choi, Eue-Keun
    Jung, Eun-Kyung
    You, So-Jeong
    Oh, Seil
    Lip, Gregory Y. H.
    KOREAN CIRCULATION JOURNAL, 2024, 54 (01) : 13 - 27
  • [8] Impact of stroke events in patients with atrial fibrillation detected by cardiac implantable electronic devices from Far East
    Nakano, M.
    Kondo, Y.
    Nakano, M.
    Hayashi, T.
    Ito, R.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 933 - 933
  • [9] Risk factors for the development of incident atrial fibrillation in patients with cardiac implantable electronic devices
    Miyazawa, Kazuo
    Kondo, Yusuke
    Nakano, Miyo
    Asuncion Esteve-Pastor, Maria
    Miguel Rivera-Caravaca, Jose
    Senoo, Keitaro
    Kobayashi, Yoshio
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 52 : 54 - 59
  • [10] Does Atrial Fibrillation Detected by Cardiac Implantable Electronic Devices Have Clinical Relevance?
    Glotzer, Taya V.
    Ziegler, Paul D.
    CARDIOLOGY CLINICS, 2014, 32 (02) : 271 - +